Isabel Neuringer
Overview
Explore the profile of Isabel Neuringer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Parrish 2nd R, Tisza M, Shah V, Tran T, Ross M, et al.
Commun Biol
. 2024 Nov;
7(1):1590.
PMID: 39609616
Most respiratory microbiome studies use amplicon sequencing due to high host DNA. Metagenomics sequencing offers finer taxonomic resolution, phage assessment, and functional characterization. We evaluated five host DNA depletion methods...
2.
3.
Velez C, Neuringer I, Schwarzenberg S
Pediatr Pulmonol
. 2024 Aug;
59 Suppl 1:S61-S69.
PMID: 39105333
The aerodigestive organs share a kindred embryologic origin that allows for a more complete explanation as to how the foregut can remain a barrier to normalcy in people with cystic...
4.
Scully K, Brenner L, Martin K, Ruazol M, Sawicki G, Uluer A, et al.
Front Endocrinol (Lausanne)
. 2024 Feb;
15:1293709.
PMID: 38379863
Introductions: Cystic fibrosis-related diabetes (CFRD) is associated with pulmonary decline, compromised nutritional status, and earlier mortality. Onset is often insidious, so screening for early detection of glycemic abnormalities is important....
5.
Kim M, Parrish 2nd R, Shah V, Ross M, Cormier J, Baig A, et al.
Res Sq
. 2024 Feb;
PMID: 38343829
Background: Most respiratory microbiome studies have focused on amplicon rather than metagenomics sequencing due to high host DNA content. We evaluated efficacy of five host DNA depletion methods on previously...
6.
Sherwood J, Castellanos L, OConnor M, Balliro C, Hillard M, Gaston S, et al.
Diabetes Care
. 2023 Oct;
47(1):101-108.
PMID: 37874987
Objective: Cystic fibrosis-related diabetes (CFRD) affects up to 50% of adults with cystic fibrosis and adds significant morbidity and treatment burden. We evaluated the safety and efficacy of automated insulin...
7.
Liew M, Mathews J, Li A, Singh R, Jaramillo S, Weiss Z, et al.
Open Forum Infect Dis
. 2023 Aug;
10(8):ofad369.
PMID: 37577118
Background: Therapeutically immunosuppressed transplant recipients exhibit attenuated responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. To elucidate the kinetics and variant cross-protection of vaccine-induced antibodies in this population,...
8.
Villavicencio M, Li S, Leifer A, Gustafson J, Osho A, Wolfe S, et al.
JTCVS Open
. 2023 Jul;
14:602-614.
PMID: 37425441
Objective: The study objective was to assess the safety and efficacy of a preemptive direct-acting antiviral therapy in lung transplants from hepatitis C virus donors to uninfected recipients. Methods: This...
9.
Winzig F, Gandhi S, Lee A, Wurstle S, Stanley G, Capuano I, et al.
Yale J Biol Med
. 2022 Dec;
95(4):413-427.
PMID: 36568830
The rise of antimicrobial resistant (AMR) bacteria is a global public health threat. AMR bacteria pose a challenging clinical problem, particularly for those with cystic fibrosis (CF) who are predisposed...
10.
Vieira J, Jesudasen S, Bringhurst L, Sui H, McIver L, Whiteson K, et al.
mSystems
. 2022 Aug;
7(5):e0036422.
PMID: 36000724
Features of the airway microbiome in persons with cystic fibrosis (pwCF) are correlated with disease progression. Microbes have traditionally been classified for their ability to tolerate oxygen. It is unknown...